Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32.3Revenue (TTM) $M0.6Net Margin (%)-487.3Altman Z-Score--
Enterprise Value $M32.0EPS (TTM) $-0.8Operating Margin %31.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-283.2Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsY
Price/Sales38.15-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-50.0ROA % (ttm)-12.4Higher Current Ratio y-yN
Dividend Yield %0.5PEG--ROE % (ttm)-18.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M3.8ROIC % (ttm)1.1Gross Margin Increase y-yN

Gurus Latest Trades with DXR

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

DXR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DXR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Feldschuh Michael RichardActing CEO & President 2016-04-15Buy300$8.064.84view
Feldschuh Michael RichardActing CEO & President 2016-04-14Buy200$8.074.71view
Feldschuh Michael RichardActing CEO & President 2016-04-11Buy200$8.064.84view
Feldschuh Michael RichardExecutive VP 2016-04-07Buy100$8.084.58view
Feldschuh Michael RichardExecutive VP 2015-08-12Buy500$6.2235.85view
Feldschuh Michael RichardExecutive VP 2015-08-06Buy200$6.5429.2view
Feldschuh Michael RichardExecutive VP 2015-08-04Buy583$6.4930.2view
Feldschuh Michael RichardExecutive VP 2015-07-28Buy500$6.4830.4view
Feldschuh Michael RichardExecutive VP 2015-07-24Buy500$6.6826.5view
Meegan Diane MarieCorporate Secretary 2015-04-10Sell1,000$7.699.88view

Press Releases about DXR :

Quarterly/Annual Reports about DXR:

    News about DXR:

    Articles On GuruFocus.com
    3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
    Weekly 3-Year Low Stocks: PBR, NJ, DWA, DXR Feb 10 2013 
    Daxor Corp Reports Operating Results (10-Q) Nov 12 2010 
    Daxor Corp Reports Operating Results (10-Q) Aug 13 2010 
    Daxor Corp Reports Operating Results (10-Q) May 11 2010 
    Daxor Corp Reports Operating Results (10-Q) Nov 12 2009 
    Daxor Corp Reports Operating Results (10-Q) Aug 13 2009 
    Daxor Corp Reports Operating Results (10-Q) May 12 2009 

    More From Other Websites
    Daxor Corporation Announces Dividend, Patent Approval, Title Change Nov 18 2016
    Two New Studies from the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society... Sep 29 2016
    Daxor Corporation Announces Two New Studies From the Mayo Clinic and Lankenau Medical Center... Sep 29 2016
    DAXOR CORP Files SEC form 8-K/A, Change in Directors or Principal Officers Sep 27 2016
    Daxor Corp. :DXR-US: Earnings Analysis: For the six months ended June 30, 2016 : September 27, 2016 Sep 27 2016
    DAXOR CORP Files SEC form 8-K, Change in Directors or Principal Officers Sep 23 2016
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2016 Sep 15 2016
    Daxor Corporation Announces Filing of Form N-CSR for June 30, 2016 Sep 15 2016
    In Heart Failure, One Size Does Not Fit All: New Mayo Clinic BVA Study Published in Journal of the... Jul 27 2016
    DAXOR CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 07 2016
    Daxor Corporation Announces Hiring of Chief Financial Officer Jun 28 2016
    Daxor Corporation Announces Hiring of Chief Financial Officer Jun 17 2016
    Real-World Impact on Heart Failure Mortality and Readmissions of Individualized Care Guided by Blood... Apr 06 2016
    University of Hawaii and The Queen's Medical Center Reports on a Study on Critically Ill Patients... Mar 09 2016
    Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent... Feb 29 2016
    Daxor Corporation Announces Return of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery Feb 17 2016
    Daxor Corporation Announces Sale of BVA-100 Blood Volume Analyzer to Nebraska Medicine Feb 08 2016
    Technical Data Drives the Market - Analyst Review of Orkla, Magic Software Enterprises, Iao Kun... Jan 29 2016
    Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as... Dec 10 2015
    Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as... Dec 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)